Product Information
DEXMETHYLPHENIDATE ER 30 MG CP is a generic product labeled by Lannett Company Inc., priced at $1.5594 per EA under NDC 00527811137. Its NADAC has been published 392 times since Apr 3, 2019.
FDA first approved this application on Oct 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Lannett Company Inc.NDC
00527811137
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210279FDA Approved
10/9/2018
TE Code
AB
On Market Since
10/9/2018
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has been published 392 times since Apr 3, 2019, and over the history we have for it it has declined 59.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5594 per EA |
|---|---|
| All-time high | $4.7909 (Feb 10, 2021) |
| All-time low | $0.7499 (May 22, 2024) |
| 52-week high | $1.9363 |
| 52-week low | $1.4839 |
| Median price | $1.8308 |
| Average price | $2.2408 |
| Largest weekly change | +83.4% (Aug 18, 2021) |
| Weeks tracked | 392 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 30 MG CP, manufactured by Lannett Company Inc., is $1.5594 per EA (NDC 00527811137), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE ER 30 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has declined 59.4%. It has been tracked across 392 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 30 MG CP?
Since Apr 3, 2019, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has ranged from a low of $0.7499 (May 22, 2024) to a high of $4.7909 (Feb 10, 2021), with a median of $1.8308 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 30 MG CP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXMETHYLPHENIDATE ER 30 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXMETHYLPHENIDATE ER 30 MG CP?
DEXMETHYLPHENIDATE ER 30 MG CP (NDC 00527811137) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.